DASA
Mr. Carlos holds a degree in Mechanical Engineering and Economics with honorable distinction from Stanford University and has been a partner at DNA Capital Consultoria since 2015.
Carlos joined Dasa in 2015 as CFO, an office he held until 2018 when he was elected as the Company’s CEO / Managing Director. In 2021, Carlos took office as Outpatient Care and Diagnostics Operations Officer, and in 2022, he left the Company’s Executive Board to become a member of Dasa’s Board of Directors.
Previously, he was a partner at Gávea Investimentos between 2008 and 2014, liable for investments in the health sector and other segments. From 2006 to 2008, he served as an associate member at Kohlberg Kravis Roberts & Co. (“KKR”), New York, participating in various private equity transactions. Carlos also worked at Morgan Stanley and JP Morgan over his career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
DASA
3 followers
Diagnosticos da America SA (DASA) is a Brazil-based company engaged in the provision of diagnostic support service. The Company's services are structured into three units: Ambulatory and Hospital, which provides clinical analyses and diagnostic imaging; Laboratory support, which provides services for small and medium-sized laboratories, and Public Health Sector, in which the Company operates through the CientificaLab brand, which focuses on providing auxiliary diagnostic support services for the public health sector. In addition, the Company is engaged in activities related to tests in food and substances to evaluate risks for the human being; import, for its own use, of medical-hospital equipment, sets for diagnostics and related material in general, and granting and administration of business franchising, including advertising and publishing fund, training and selection of labor, supplying of equipment and research material suppliers, among others.